AstraZeneca And Daiichi Sankyo's Datroway Gets US Approval For Metastatic HR+ Breast Cancer
British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...
Cancer Stocks In The Spotlight: The Immunotherapy Revolution
Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...
$258 Billion Market: Why Cancer Immunotherapy Is Transforming Both Care And Portfolios
The market is responding to this breakthrough. Analysts at Exactitude Consultancy predict that the global immunotherapy ...
RIPR: The Public's Radio20h
Many doctors don’t discuss sex after cancer. But survivors wish they would
Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...
Cure Today12h
Long-Term Patient Care Focuses on Precision-Based Therapy in Breast Cancer
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
STAT14h
AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
Targeted Oncology19h
The Targeted Pulse: Check Out Positive and Negative Updates in Head and Neck Cancer, and How the FDA is Handling Advancements in Lung Cancer Treatment
HNSCC, whereas the combination of durvalumab and cetuximab showed limited success. Abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and Lazertinib ...
Hosted on MSN17h
15 Herbs and Spices That Help in Cancer Prevention and Treatment
Cancer is a significant health challenge worldwide, impacting both developed and developing countries. According to a 2008 ...
pancan11h
ABOUT Pancreatic Cancer
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.